BeStock  
Stocks › Biotechnology › SLN

Silence Therapeutics SLN

US equityMarket cap rank #3022Biotechnology
$19.81 +$0.00 (0.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $19.81 0.00%
Open$19.81
Prev close$19.81
Day range$19.80 – $19.83
Volume399.1K
Market cap$1.23B
P/E (TTM)–
Dividend yield–

SLN Stock News

Headlines matching Silence Therapeutics or the SLN ticker, most recent first.

  • H.C. Wainwright Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $75Market news · 22 Sep 2026 · Direct mention
  • William Blair Maintains Silence Therapeutics(SLN.US) With Buy RatingMarket news · 11 Sep 2026 · Direct mention
  • Chardan Capital Maintains Silence Therapeutics(SLN.US) With Buy RatingMarket news · 17 Aug 2026 · Direct mention
  • Silence Therapeutics Expects Offering to Close on or About Aug. 13 SLNDow Jones · 12 Aug 2026 · Direct mention
  • Morgan Stanley Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $32Market news · 11 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Silence Therapeutics(SLN.US), With a Forecast Between $27 to $75Market news · 11 Aug 2026 · Direct mention
  • Cantor Fitzgerald Initiates Silence Therapeutics(SLN.US) With Buy RatingMarket news · 24 Jun 2026 · Direct mention
  • Morgan Stanley Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $25Market news · 12 Jun 2026 · Direct mention
  • Chardan Capital Maintains Silence Therapeutics(SLN.US) With Buy Rating, Cuts Target Price to $27 NegativeMarket news · 8 May 2026 · Direct mention
  • Silence Therapeutics (SLN) Receives a Buy From H.C. WainwrightTipRanks · 27 May 2026 · Direct mention
  • H.C. Wainwright Reaffirms Their Buy Rating on Silence Therapeutics (SLN)TipRanks · 7 Apr 2026 · Direct mention
  • William Blair Maintains Silence Therapeutics(SLN.US) With Buy Rating, Announces Target Price $5.5Market news · 6 Mar 2026 · Direct mention
  • Goldman Sachs Maintains Silence Therapeutics(SLN.US) With Sell Rating, Maintains Target Price $4Market news · 6 Mar 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR), Medline, Inc. Class A (MDLN) and Silence Therapeutics (SLN)TipRanks · 26 Feb 2026 · Direct mention
  • Earnings Flash (SLN) Silence Therapeutics Posts Q3 Net Loss $0.08 a Share, Vs. FactSet Est of $0.08 Loss NegativeMT Newswires · 12 Nov 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on SLN.

Sign in to join the discussion.

Scroll to Top